Assessing the current dealmaking environment for psychedelic medicine.

Pharma Intelligence Podcasts

Sep 18, 202619:41Business

Joseph Haas and Emma Wille overview the dealmaking environment for psychedelic medicine given recent developments in the space: Eli Lilly's $2.8 billion acquisition of AtaiBeckley in July, the imminent FDA filing of Comp...

Related Episodes

Continue listening to more episodes from Pharma Intelligence Podcasts.

Strategic Intent: Rubedo’s Seno-Adaptive Bet On Longevity Medicine

Sep 21, 2026 - 40:09

In this episode of Strategic Intent, In Vivo senior reporter David Wild speaks with Frederick Beddingfiel...

Digital Health Roundup: Oura Plans IPO, FDA’s Home Health, Digital Tools For Alzheimer’s Detection

Sep 16, 2026 - 21:02

In this month: Marion Webb highlights Oura’s IPO, new partnerships, and a class-action lawsuit. George Un...

Strategic Intent: Next‑Generation Cancer Vaccines And Nouscom’s Strategy For Interception And Personalization

Sep 15, 2026 - 36:13

"Personalized and off‑the‑shelf cancer vaccines are moving from concept to clinic, raising new questions...

Scaling Self-Care In Asia Pacific, With APSMI's Rachmadi Joesoef and Anama O'Reilly

Sep 15, 2026 - 37:06

In this episode of Over the Counter, now also in video, HBW Insight talks to Rachmadi Joesoef, APSMI chai...

Drug Fix: Increasing US FDA Leadership Stability And Where All The Adcomms Have Gone

Sep 11, 2026 - 35:48

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, Editor-in-Chief Nielsen Hobbs and...

Strategic Intent: Evolving Requirements Of Life Sciences Leadership

Sep 8, 2026 - 21:17

In this episode of Strategic Intent, Nick Stephens, chairman of the recruitment and executive placement c...

Drug Fix: US FDA Commissioner Nominee Heidi Overton’s Resume And COVID-19 Vaccine Trial Changes

Sep 4, 2026 - 38:09

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, Senior Reporter Maaisha Osman, and...

Proof Of Concept: How A Charity Bridges Lab And Clinic

Sep 4, 2026 - 21:27

Cancer Research UK is best known for funding science. But its commercial arm, Cancer Research Horizons, d...